BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1708598)

  • 1. [Histochemical and histomorphometric studies on growth fractions in human breast carcinoma].
    Hahn J; Linhart W; Müller H; Renz S; Schneider M
    Verh Dtsch Ges Pathol; 1990; 74():262-7. PubMed ID: 1708598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of proliferating cell nuclear antigen (PCNA), nucleolar organizer regions (NORs) and mitotic activity in epithelial ovarian tumors].
    Yamanaka S; Nagai N; Ohama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Mar; 45(3):234-40. PubMed ID: 8098347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleolar organizer regions and Ki-67 immunostaining in ductal breast cancer: a comparative study.
    Canepa M; Gambini C; Sementa AR; Borgiani L; Rovida S
    Pathologica; 1990; 82(1078):125-32. PubMed ID: 2168032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of the proliferation (by detection of Ki-67 antigen) and activity of nucleolar organizer regions in breast cancer cells].
    Uporov AV; Tsyrlina EV; Pozharisskiĭ KM
    Vopr Onkol; 1998; 44(3):316-24. PubMed ID: 9695779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative activity is a significant prognostic factor in male breast carcinoma.
    Pich A; Margaria E; Chiusa L
    Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characterization of nucleolar organizers in carcinomatous mammmary lesions].
    Kharrat A; Krichen H; Tabbene F; Sellami M
    Arch Inst Pasteur Tunis; 1991; 68(3-4):243-9. PubMed ID: 1824505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A; Söylemez F; Ensari A
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The proliferative activity in epithelial hyperplasia of the breast].
    Kaneko M; Arihiro K; Fujii S; Inai K
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():46-51. PubMed ID: 7747992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of nucleolar organizer region-associated proteins in breast malignancy.
    Smith R; Crocker J
    Histopathology; 1988 Feb; 12(2):113-25. PubMed ID: 2452777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
    Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
    Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of diagnosis and prognosis for breast carcinoma with examination of Ag-NORs].
    Xiong X; Huang Y; Wan Y
    Zhonghua Wai Ke Za Zhi; 1995 Oct; 33(10):609-10. PubMed ID: 8731895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor proliferative fraction in infiltrating duct carcinoma.
    Kesari AL; Chellam VG; Nair PP; Madhavan J; Nair P; Nair MK; Pillai MR
    Gen Diagn Pathol; 1997 Dec; 143(4):219-24. PubMed ID: 9489954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications of interphasic NORs as a diagnostic parameter of atypical lesions of the female breast.
    Di Stefano D; Scucchi L; Limiti MR; Mingazzini PL; Marinozzi V
    Anticancer Res; 1996; 16(4A):1953-61. PubMed ID: 8712727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of Ki-67 and argyrophilic nucleolar organizer region staining for lymph node metastasis in gastric cancer.
    Kakeji Y; Korenaga D; Tsujitani S; Haraguchi M; Maehara Y; Sugimachi K
    Cancer Res; 1991 Jul; 51(13):3503-6. PubMed ID: 2054789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
    Markiewski M; Domagała W
    Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleolar organizer regions in human breast cancer.
    Roller E; Fritz P; Wicherek C; Klumpp B; Lauinger J; Mischlinski A; Wanner B; Schumacher K
    Zentralbl Pathol; 1993 Aug; 139(3):195-9. PubMed ID: 8218120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleolar organizer regions in breast cytology material.
    Rath-Wolfson L; Hamel I; Halpern M; Klein B; Gal R
    Acta Cytol; 1995; 39(5):852-7. PubMed ID: 7571959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
    Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
    Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ki 67 growth fraction in carcinomas and benign lesions of the breast].
    Kunz J; Schmidt A
    Zentralbl Pathol; 1993 Aug; 139(3):201-5. PubMed ID: 8218121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.